Bennabi D

Department of Clinical Psychiatry, Centre d'Investigation Clinique, DomaineSanté Mentale et Neurosciences, Inserm CIC 1431 Centre Hospitalier Universitaire de Besançon, 25030, Besançon Cedex, France.

2 papers

ArticleKetamine

Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report.

Young AH, Baune BT, Benatti B +13

Europe PMC2026
ArticleKetamine

French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.

Yrondi A, Javelot H, Nobile B +7

Europe PMC2025